PMK 007 CVD Heart Power Rebuild
Natural health product licensed in Canada
- Other names
- CVD Heart Power Rebuild, Heart Health
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80032809
- Status
- Active licence
- Licence date
- 14 June 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crataegus laevigata Source : Fruit Extraction ratio : 10:1 Dry plant equivalent : 150 milligramme | 15 milligramme | Not calculated |
| L-arginine Source : Monohydrochlorure de L-arginine | 750 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, microcristalline, Eau purifiée, Glycérine, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 4 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD). Used in Herbal Medicine to help reduce elevated blood lipid levels in adults. Used in Herbal Medicine to help reduce hyperlipidaemia in adults. Used in Herbal Medicine to help support cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience gastrointestinal discomfort.
- Précautions et mises en garde
Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases or erectile dysfunction. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult a health care practitioner prior to use if you have a renal/kidney disease or if you are following a low protein diet. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood pressure medication, protease inhibitors, cardiac glycosides such as digitalis/digoxin.
- Contre-indications
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use. Do not use if you have had a heart attack/myocardial infarction.
Source
Official Health Canada record, licence 80032809
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Crataegus laevigata
Read the warning, when it applies and the studies cited
Hawthorn
Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.